Jideytro will now enter a lung cancer niche dominated by Pfizer’s Lorbrena.
The new investment increases BeOne Medicines’ total spend on US manufacturing facilities to over $1bn.
AFTX-201 is an investigational gene therapy delivered through a single intravenous infusion.
The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for dotinurad.
Lu AH69593 is currently being studied in a Phase Ib clinical trial focused on patients with narcolepsy.
Executive vice-president James Choi discusses the CDMO’s growth strategy and acquiring its first US manufacturing site from GSK.
